(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ANDOSAN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ANDOSAN

ST13

US500000079364782

Class

5

Filing

79364782

Registration

7383414

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

27

Latest update

09/27/2025

Trademark type

Word

Nice classes

5

Filing date

02/17/2023

Registration date

05/14/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/14/2024

Last transaction

09/27/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

NO

Examiner

OH,HYUN-JUNG

Law office

O20

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

M. A. (pessoa física)

Representatives

Christian D. Abel Onsagers AS

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations and natural remedy preparations for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; nutraceutical preparations for therapeutic or medical purposesnutraceuticals for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; dietary and nutritional supplements; health food supplements for humans; nutraceuticals for use as dietary supplements

Publications

History of USPTO decisions and trademark events.

27 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

09/26/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

11/30/2024

FICS

FINAL DISPOSITION NOTICE SENT TO IB

11/08/2024

FIMP

FINAL DISPOSITION PROCESSED

11/08/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

08/14/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/14/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

05/14/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/04/2024

GPNX

NOTIFICATION PROCESSED BY IB

02/27/2024

PUBO

PUBLISHED FOR OPPOSITION

02/27/2024

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

02/07/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/07/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/07/2024

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

02/07/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/18/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/19/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/19/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/19/2023

RFNT

REFUSAL PROCESSED BY IB

12/19/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

11/29/2023

RFRR

REFUSAL PROCESSED BY MPU

11/29/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

11/28/2023

CNRT

NON-FINAL ACTION WRITTEN

11/27/2023

DOCK

ASSIGNED TO EXAMINER

11/16/2023

MAFR

APPLICATION FILING RECEIPT MAILED

03/14/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/10/2023

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

03/09/2023

Continuous trademark protection

Get notified about every new filing that threatens ANDOSAN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.